Physician profile
Amit Arora
NPI 1619143799
$8,735.78
in general payments reported to CMS, 2019-2025
26 companies · $2,414 in 2025
The $2,414 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,711 · 2020: $484 · 2021: $718 · 2022: $1,772 · 2023: $686 · 2024: $952 · 2025: $2,414.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,556 · Travel and Lodging: $495.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,556.35 |
| Travel and Lodging | $494.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,532.55 | 2022-2023 | |
| Abiomed | $1,250.34 | 2020-2025 | Impella |
| Cardiovascular Systems INC. | $1,247.86 | 2019-2022 | |
| Atricure, INC. | $1,073.27 | 2021-2025 | Synergy Ablation System, Atricure Cryoice Cryosphere Cryoablation System, Atriclip Laa Exclusion System |
| Endologix LLC | $718.04 | 2019-2025 | Torus Stent Graft System, Endocross Device |
| Medtronic, INC. | $563.50 | 2022-2025 | Penditure, Valiant Captivia, Corevalve Evolut R |
| Medela LLC | $436.02 | 2025 | |
| Medtronic Vascular, INC. | $409.34 | 2019-2020 | |
| Edwards Lifesciences Corporation | $305.53 | 2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Intuitive Surgical, INC. | $286.95 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $236.62 | 2019-2023 | Xarelto |
| Lemaitre Vascular, INC. | $219.38 | 2022-2024 | Artegraft Vascular Graft, Xenosure Biologic Patch, Restoreflow |
| Acadia Pharmaceuticals INC | $99.78 | 2025 | Nuplazid |
| Angiodynamics, INC. | $93.59 | 2021-2022 | |
| W. L. Gore & Associates, INC. | $53.81 | 2025 | Gore Viabahn Endoprosthesis With Heparin |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $38.53 | 2023 | Puraply |
| Philips North America LLC | $29.60 | 2021 | |
| Avinger INC. | $20.74 | 2022 | |
| Astrazeneca Pharmaceuticals Lp | $18.31 | 2021 | |
| Novo Nordisk INC | $16.54 | 2025 | Wegovy |
| Bolton Medical INC | $15.89 | 2025 | Treo Abdominal Stent-Graft System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $14.70 | 2019 | |
| Davol INC. | $14.54 | 2023 | Phasix Mesh |
| Ucb, INC. | $14.41 | 2024 | Bimzelx |
| Penumbra, INC. | $13.95 | 2019 | |
| Kls-Martin L.P. | $11.99 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amit Arora listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.